Biocon's Cranbury Facility in US Passes FDA Inspection, Supports Expansion Plans
Biocon’s inspection concluded with a single observation, which the company will address within the stipulated timeframe, and it is not expected to impact ongoing business operations
New Jersey | 15/10/2025 | By Dineshwori
Enzene, Aurobindo and Biocon Boost US Manufacturing with Major New Jersey Expansions
This month, three leading Indian firms — Enzene Biosciences, Aurobindo Pharma, and Biocon — have inaugurated major facilities in New Jersey, underscoring a growing trend of onshore investment by Indian pharma companies.
New Jersey | 18/09/2025 | By Dineshwori | 197
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy